Clindamycin Palmitate Hydrochloride (Marlex Pharmaceuticals Inc)
Welcome to the PulseAid listing for the Clindamycin Palmitate Hydrochloride drug offered from Marlex Pharmaceuticals Inc. This Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Marlex Pharmaceuticals Inc |
| NON-PROPRIETARY NAME: | Clindamycin Palmitate Hydrochloride |
| SUBSTANCE NAME: | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-08-01 |
| END MARKETING DATE: | 0000-00-00 |
Clindamycin Palmitate Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Clindamycin Palmitate Hydrochloride from Marlex Pharmaceuticals Inc |
| LABELER NAME: | Marlex Pharmaceuticals Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(mg/5mL) |
| START MARKETING DATE: | 2015-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10135-569_252ab443-71b1-442b-b990-73794cec49f4 |
| PRODUCT NDC: | 10135-569 |
| APPLICATION NUMBER: | ANDA203513 |
Other CLINDAMYCIN PALMITATE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
